US-based biopharmaceutical company Allergan has completed the acquisition of LifeCell, the regenerative medicine unit of Acelity.

Acelity’s regenerative medicines business and dermal matrix products are added to Allergan’s portfolio as a result of the acquisition.

Biopharmaceutical services provider Parexel International is set to acquire The Medical Affairs Company (TMAC), a full-service contract medical services provider founded in 2007 and based in the US.

Parexel intends to gain new and distinct medical affairs outsourcing capabilities through the acquisition.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now